STOCK TITAN
  1. Home
  2. Sec-filings
  3. TLSI
  4. [Form 4] TriSalus Life Sciences, Inc. Insider Trading Activity

TriSalus (TLSI) director granted RSU and stock option awards

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

TriSalus Life Sciences director Mats Wahlstrom reported new equity compensation grants. He received 34,226 restricted stock units that vest fully on May 14, 2026, payable in common stock, subject to his continued board service.

He also received a Retainer RSU Award of 37,602 units, taken in lieu of 2026 cash board retainer fees. These RSUs vest in three equal quarterly installments through the remainder of 2026, conditioned on continued service. In addition, he was granted a director stock option for 75,204 shares of common stock at an exercise price of $2.5200 per share, vesting in full on May 14, 2026 and expiring on May 13, 2036.

The filing also shows substantial indirect common stock holdings through Leonard Capital LLC and HW Investment Partners, LLC, where Wahlstrom shares voting and investment discretion, and he disclaims beneficial ownership of HW Investment securities beyond his pecuniary interest.

Positive

  • None.

Negative

  • None.
Insider Wahlstrom Mats
Role null
Type Security Shares Price Value
Grant/Award Director Stock Option (right to buy) 75,204 $0.00 --
Grant/Award Common Stock 37,602 $0.00 --
Grant/Award Common Stock 34,226 $0.00 --
holding Common Stock -- -- --
holding Common Stock -- -- --
Holdings After Transaction: Director Stock Option (right to buy) — 276,149 shares (Direct, null); Common Stock — 53,329 shares (Direct, null); Common Stock — 1,444,447 shares (Indirect, By Leonard Capital LLC)
Footnotes (1)
  1. Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU award shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer. Represents grant of restricted stock units (the "Retainer RSU Award") payable solely in common stock of the Issuer. The Reporting Person elected to receive the Retainer RSU Award in lieu of 2026 board service retainer cash fees provided for under the Issuer's Non-Employee Director Compensation Policy. The shares subject to the Retainer RSU Award shall vest quarterly in equal one-third installments through the remainder of 2026, subject to the Reporting Person's continued service with the Issuer. The Reporting Person shares voting and investment discretion with his spouse with respect to the shares held directly by Leonard Capital LLC. The Reporting Person is a managing member of HW Investment Partners, LLC ("HW Investment") and shares voting and investment discretion with respect to the shares held directly by HW Investment. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. The shares subject to the option shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer.
RSU Award size 34,226 shares Restricted stock units vesting on May 14, 2026
Retainer RSU Award 37,602 shares RSUs in lieu of 2026 cash retainer, vesting quarterly
Director stock option size 75,204 shares Option grant for common stock
Option exercise price $2.5200 per share Director stock option strike price
Option expiration May 13, 2036 Director stock option expiration date
Indirect holdings via HW Investment 1,370,028 shares Common stock held indirectly by HW Investment Partners, LLC
Indirect holdings via Leonard Capital 1,444,447 shares Common stock held indirectly by Leonard Capital LLC
Direct common stock after RSU grant 87,555 shares Total direct common shares following one RSU transaction
restricted stock units financial
"Represents grant of restricted stock units (the "RSU Award") payable solely in common stock"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Retainer RSU Award financial
"Represents grant of restricted stock units (the "Retainer RSU Award") payable solely in common stock"
Non-Employee Director Compensation Policy financial
"in lieu of 2026 board service retainer cash fees provided for under the Issuer's Non-Employee Director Compensation Policy"
pecuniary interest financial
"disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein"
Director Stock Option financial
"Director Stock Option (right to buy) with an exercise price of 2.5200"
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Wahlstrom Mats
(Last)(First)(Middle)
6272 W. 91ST AVENUE
(Street)
WESTMINSTER COLORADO 80031
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
TriSalus Life Sciences, Inc. [ TLSI ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/14/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/14/2026A37,602(1)A$053,329D
Common Stock05/14/2026A34,226(2)A$087,555D
Common Stock1,444,447IBy Leonard Capital LLC(3)
Common Stock1,370,028IBy HW Investment Partners, LLC(4)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Director Stock Option (right to buy)$2.5205/14/2026A75,204 (5)05/13/2036Common Stock75,204$0276,149D
Explanation of Responses:
1. Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU award shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer.
2. Represents grant of restricted stock units (the "Retainer RSU Award") payable solely in common stock of the Issuer. The Reporting Person elected to receive the Retainer RSU Award in lieu of 2026 board service retainer cash fees provided for under the Issuer's Non-Employee Director Compensation Policy. The shares subject to the Retainer RSU Award shall vest quarterly in equal one-third installments through the remainder of 2026, subject to the Reporting Person's continued service with the Issuer.
3. The Reporting Person shares voting and investment discretion with his spouse with respect to the shares held directly by Leonard Capital LLC.
4. The Reporting Person is a managing member of HW Investment Partners, LLC ("HW Investment") and shares voting and investment discretion with respect to the shares held directly by HW Investment. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
5. The shares subject to the option shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer.
Remarks:
/s/ Mary Szela, Attorney-in-Fact05/15/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What equity awards did TriSalus (TLSI) director Mats Wahlstrom receive?

Mats Wahlstrom received two restricted stock unit grants and a director stock option award. The RSU awards cover 34,226 shares and 37,602 shares, and the option covers 75,204 shares of common stock at a fixed exercise price.

How do the new RSU awards for TriSalus (TLSI) director vest?

One RSU award of 34,226 shares vests fully on May 14, 2026, subject to continued service. The 37,602-share Retainer RSU Award vests in three equal quarterly installments during 2026, also contingent on Wahlstrom’s continued service with TriSalus Life Sciences.

What are the key terms of the TriSalus (TLSI) director stock option grant?

The director stock option covers 75,204 shares of common stock at an exercise price of $2.5200 per share. It vests fully on May 14, 2026 and expires on May 13, 2036, assuming continued service with TriSalus Life Sciences.

Did TriSalus (TLSI) director Wahlstrom take equity instead of cash fees?

Yes. Wahlstrom elected to receive a Retainer RSU Award of 37,602 restricted stock units instead of 2026 board service retainer cash fees. These RSUs vest in three equal quarterly installments over the remaining 2026 service period, subject to continued service.

What indirect TriSalus (TLSI) holdings are reported for Mats Wahlstrom?

The filing reports indirect common stock holdings through Leonard Capital LLC and HW Investment Partners, LLC. Wahlstrom shares voting and investment discretion over these entities’ shares and disclaims beneficial ownership of HW Investment securities beyond his pecuniary interest.